CVS Health’s 2022 Health Care Insights Study finds that female U.S. consumers are very interested in engaging health care providers in discussions about their holistic health, mental health, and physical health goals, although women post-pandemic strug…
Anxiety is the most common mental health disorder in the U.S., with the annual overall healthcare expenditure associated with anxiety disorders being estimated at $1,657 per person and the total direct medical expenditure estimated at approximately $33…
Even though the WHO recognized infertility as a disease and a public health problem, its incidence is consistently increasing. But, technology can help those on this frustrating journey. These eight companies are redefining what accessible and affordab…
These seven highly innovative companies in the femtech space are bringing new game-changing solutions to the market, disrupting sectors where we haven’t seen much innovation in recent years and changing the narrative around conditions and illnesses tha…
Lack of awareness, symptoms, standardized processes and technologies for diagnosis are only some of the key areas that impede or negatively impact the journey of patients with CAD/PAD, according to the latest study conducted by Abbott – ‘Beyond Interve…
Pandemic has exacerbated existing healthcare inequalities and disparities in how accessible and inclusive healthcare provision is in some countries. But, there are many innovative companies out there working on solutions that have the potential to chan…
After surviving multiple cardiac arrests hypoxic strokes, Shavini Fernando invented OxiWear – the first non-intrusive wearable that would provide continuous readings at medical-grade accuracy.
Earlier this year, Female Founders Fund conducted research concluding that “responding to the needs of women experiencing menopause is a $600 billion opportunity for companies”. Meet eight female founders and entrepreneurs who are shaping the future of…
Amma pregnancy tracker, the global femtech app for pregnant women and their families, announced today $2 million in Pre-Series A funding from the U.S., CIS, and Asia-based investors, at a post-money valuation of $28 million.
Even is a medical company focused on improving the quality of life of medication users. Its nutrient repletion systems are designed to address Medication-Induced Nutrient Depletions and mitigate potential side effects of antidepressants, birth control,…